Physico-biochemical studies on cationic gemini surfactants: Role of spacer

Role of Gemini Surfactants with Variable Spacers and SiO2 Nanoparticles in ct-DNA Compaction and Applications toward In Vitro/In Vivo Gene Delivery

Compaction of calf thymus DNA (ct-DNA) by two cationic gemini surfactants, 12-4-12 and 12-8-12, in the absence and presence of negatively charged SiO₂ nanoparticles (NPs) (∼100 nm) has been explored using various techniques. 12-8-12 having a longer hydrophobic spacer induces a greater extent of ct-DNA compaction than 12-4-12, which becomes more efficient with SiO₂ NPs. While 50% ct-DNA compaction in the presence of SiO₂ NPs occurs at ∼77 nM of 12-8-12 and ∼130 nM of 12-4-12, but a conventional counterpart surfactant, DTAB, does it at its concentration as high as ∼7 μM. Time-resolved fluorescence anisotropy measurements show changes in the rotational dynamics of a fluorescent probe, DAPI, and helix segments in the condensed DNA. Fluorescence lifetime data and ethidium bromide exclusion assays reveal the binding sites of surfactants to ct-DNA. 12-8-12 with SiO₂ NPs has shown the highest cell viability (≥90%) and least cell death in the human embryonic kidney (HEK) 293 cell lines in contrast to the cell viability of ≤80% for DTAB. These results show that 12-8-12 with SiO₂ NPs has the highest time and dose-dependent cytotoxicity compared to 12-8-12 and 12-4-12 in the murine breast cancer 4T1 cell line. Fluorescence microscopy and flow cytometry are performed for in vitro cellular uptake of YOYO-1-labeled ct-DNA with surfactants and SiO₂ NPs using 4T1 cells after 3 and 6 h incubations. The in vivo tumor accumulation studies are carried out using a real-time in vivo imaging system after intravenous injection of the samples into 4T1 tumor-bearing mice. 12-8-12 with SiO₂ has delivered the highest amount of ct-DNA in cells and tumors in a time-dependent manner. Thus, the application of a gemini surfactant with a hydrophobic spacer and SiO₂ NPs in compacting and delivering ct-DNA to the tumor is proven, warranting its further exploration in nucleic acid therapy for cancer treatment.

Effect of Spacer Structures on the Interfacial Adsorption and Micelle Properties of Quaternary Ammonium Salt-Based Gemini Surfactants

In this study, we synthesized quaternary ammonium salt-based gemini surfactants, 2C₁₂(Spacer), with different spacer structures using ethylenediamine derivatives, and investigated their adsorption and aggregation properties by measuring their electrical conductivity, surface tension, fluorescence, and viscosity in conjunction with dynamic light scattering and small-angle X-ray scattering studies to investigate the effect of spacer structures on the properties of the gemini surfactants. The gemini surfactants with spacers containing nitrogen and oxygen atoms were highly soluble in water, whereas those with rigid spacers containing diethylene and triethylene chains exhibited low water solubility. The adsorption and orientation of the gemini surfactants at the air/water interface were significantly affected by the spacer length. Among the synthesized gemini surfactants, the one with the N,N'-dimethylpiperazine spacer showed the highest surface activity. In contrast, the gemini surfactant with the 1-methyl-4-[2-(N,N-dimethylammonio)ethyl]piperazin-1-ium spacer containing an ethylene chain attached to the amino group in the N,N'-dimethylpiperazine spacer (2C₁₂(2/2-N-2)) adsorbed efficiently. However, due to the increased spacer length, this surfactant was unable to orient efficiently at the air/water interface.

Cationic gemini surfactant properties, its potential as a promising bioapplication candidate, and strategies for improving its biocompatibility: A review

Gemini surfactants consist of two cationic monomers of a surfactant linked together with a spacer. The specific structure of a cationic gemini surfactant is the reason for both its high surface activity and its ability to decrease the surface tension of water. The high surface activity and unique structure of gemini surfactants result in outstanding properties, including antibacterial and antifungal activity, anticorrosion properties, unique aggregation behaviour, the ability to form various structures reversibly in response to environmental conditions, and interactions with biomacromolecules such as DNA and proteins. These properties can be tailored by selecting the optimal structure of a gemini surfactant in terms of the nature and length of its alkyl substituents, spacer, and head group. Additionally, regarding their properties, comparison with their monomeric counterparts demonstrates that gemini surfactants have higher performance efficacy at lower concentrations. Hence, less material is needed, and the toxicity is lower. However, there are some limitations regarding their biocompatibility that have led researchers to develop amino acid-based and sugar-based gemini surfactants. Owing to their remarkable properties, cationic gemini surfactants are promising candidates for bioapplications such as drug delivery systems, gene carriers, and biomaterial surface modification.

Self-Assembly Properties of Cationic Gemini Surfactants with Biodegradable Groups in the Spacer

: Self-assembly properties of cationic gemini surfactants with biodegradable amide or ester groups in the spacer were investigated utilising time-resolved fluorescence quenching, dynamic light scattering and zeta potential measurements. A correlation between aggregation parameters such as micelle aggregation number, micelle size and zeta potential with the structure of gemini molecules was made. For gemini molecules with medium spacer lengths, micelle aggregation number does not change much with the surfactant concentration. When the spacer is extended, a stronger aggregation tendency is observed for gemini surfactant molecules with two ester groups in the spacer and the aggregation number increases. The assumption of stronger aggregation of ester-based gemini molecules at larger spacer number values is also documented by measurements of the size and zeta potential of ester-based micelles. The explanation of the difference in aggregation ability of amide-based and ester-based gemini molecules is related to the structural features of gemini molecules, notably to the larger flexibility and denser arrangement of ester-based gemini molecules in a micelle. To support this assumption, optimised 3D models of the studied gemini molecules were constructed. Correspondingly, the calculations show smaller size and interfacial area for ester-based gemini conformers.

Aqueous solution behaviour and solubilisation properties of octadecyl cationic gemini surfactants and their comparison with their amide gemini analogues

Gemini surfactants 18-s-18(Et), comprised of two ethylammonium headgroups and two alkyl tails with m = 18 carbon atoms with spacers of s = 4, 6, 8 and 10 linking the headgroups (alkanediyl-α,ω-bis(diethyloctadecylammonium bromides)), were obtained. Their aqueous solution behaviour, including adsorption at the interface and aggregation in solution, was followed by tensiometric, conductometric and spectroscopic methods. The critical micelle concentration (CMC) of the surfactants decreased with increasing spacer length. The size of 18-s-18(Et) aggregates formed at concentrations of 10 and 40 CMC measured by DLS varied with the elongation of the spacer. Visualisation of aggregated surfactant structures at 40 CMC by cryo-TEM evidenced the formation of different morphologies depending on spacer length. Gemini with s = 4 formed elongated, cylindrical micelles, while geminis of s = 6, 8 and 10 self-assembled into vesicles. The ability of the studied geminis to solubilise hydrophobic dye Sudan I in water was determined as a function of surfactant concentration, demonstrating their high efficiency. Results for 18-s-18(Et) geminis were compared with those previously obtained for their analogues containing an amide group placed between headgroups and tails. The significant impact of amide groups on the surface activity and aggregation properties of gemini surfactants was evidenced and is related to hydrogen-bond formation by amide-containing compounds.

Advances in the synthesis, molecular architectures and potential applications of gemini surfactants

Gemini surfactants have been the subject of intensive scrutiny by virtue of their unique combination of physical and chemical properties and being used in ordinary household objects to multifarious industrial processes. In this review, we summarize the recent developments of gemini surfactants, highlighting the classification of gemini surfactants based on the variation in headgroup polarity, flexibility/rigidity of spacer, hydrophobic alkyl chain and counterion along with potential applications of gemini surfactants, depicting the truly remarkable journey of gemini surfactants that has just come of age. We have focused on those objectives which will act as suitable candidates to take the field forward. The preceding information will permit us to estimate the effect of structural variation on the aggregation behavior of gemini surfactants for nanoscience and biological applications like antimicrobial, anti-fungal agent, better gene and drug delivery agent with low cytotoxicity and biodegradability, which makes them more advantageous for a number of technological processes and hence reduces the impact of these gemini surfactants on the environment.

Effect of counterions on the micellization and monolayer behaviour of cationic gemini surfactants

The effect of various inorganic and organic counterions on the aggregation behavior of gemini surfactants was examined to investigate the dominant influence of the anions on their micellization and aggregation behavior.

Inhaled gene delivery: a formulation and delivery approach

INTRODUCTION

Gene therapy is a potential alternative to treat a number of diseases. Different hurdles are associated with aerosol gene delivery due to the susceptibility of plasmid DNA (pDNA) structure to be degraded during the aerosolization process. Different strategies have been investigated in order to protect and efficiently deliver pDNA to the lungs using non-viral vectors. To date, no successful therapy involving non-viral vectors has been marketed, highlighting the need for further investigation in this field. Areas covered: This review is focused on the formulation and delivery of DNA to the lungs, using non-viral vectors. Aerosol gene formulations are divided according to the current delivery systems for the lung: nebulizers, dry powder inhalers and pressurized metered dose inhalers; highlighting its benefits, challenges and potential application. Expert opinion: Successful aerosol delivery is achieved when the supercoiled DNA structure is protected during aerosolization. A formulation strategy or compounds that can protect, stabilize and efficiently transfect DNA into the cells is desired in order to produce an effective, low-cost and safe formulation. Nebulizers and dry powder inhalers are the most promising approaches to be used for aerosol delivery, due to the lower shear forces involved. In this context it is also important to highlight the importance of considering the 'pDNA-formulation-device system' as an integral part of the formulation development for a successful nucleic acid delivery.